Mallinckrodt (NYSE: MNK) shares are trading higher on Wednesday.
The company announced it received clearance from Health Canada to start on a pilot trial of high dose inhaled nitric oxide therapy for coronavirus infection and associated lung complications.
Mallinckrodt is a manufacturer of specialty pharmaceuticals, generic drugs and imaging agents.
Mallinckrodt's stock was trading up 16% to $2.30 per share in Wednesday’s pre-market session. The stock has a 52-week high of $23.90 and a 52-week low of $1.
Related Links:
Mallinckrodt Plummets On Report Of Possible Generics Business Bankruptcy
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
"Trading" - Google News
April 01, 2020 at 08:08PM
https://ift.tt/3aAezmR
Why Mallinckrodt's Stock Is Trading Higher Today - Benzinga
"Trading" - Google News
https://ift.tt/2tBJjTS
Shoes Man Tutorial
Pos News Update
Meme Update
Korean Entertainment News
Japan News Update
Bagikan Berita Ini
0 Response to "Why Mallinckrodt's Stock Is Trading Higher Today - Benzinga"
Post a Comment